Ardent Health, Inc.
For the period ended Mar 31, 2025. Filed May 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 7, 2025
ARDT$17.93-0.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
During thethree months ended March 31, 2025, we made the following purchases of our equity securities that are registered
pursuant to Section 12(b) of the Securities Exchange Act of 1934:
| Period | Total Number of Shares Purchased(1) | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(2) | Maximum Number of Shares That May Yet Be Purchased Under the Plans or Programs(2) |
|---|---|---|---|---|
| January 1, 2025 - January 31, 2025 | 1,212 | $14.25 | — | — |
| February 1, 2025 - February 28, 2025 | — | — | — | — |
| March 1, 2025 - March 31, 2025 | 81,523 | 13.75 | — | — |
| Total | 82,735 | $13.76 | — | — |
| (1) | Represents 82,735 shares withheld by us to satisfy the payment of tax obligations related to the vesting of restricted stock unit awards. |
| (2) | We had no publicly announced plans or open market repurchase programs for shares of our common stock during the three months ended March 31, 2025. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.